Previous Close | 4.2200 |
Open | 4.1900 |
Bid | 4.1000 x 900 |
Ask | 4.1200 x 1000 |
Day's Range | 4.1200 - 4.2689 |
52 Week Range | 3.8030 - 8.0250 |
Volume | |
Avg. Volume | 31,714 |
Market Cap | 54.562M |
Beta (5Y Monthly) | 1.27 |
PE Ratio (TTM) | 4.20 |
EPS (TTM) | 0.9820 |
Earnings Date | Apr 27, 2022 - May 02, 2022 |
Forward Dividend & Yield | 0.12 (2.78%) |
Ex-Dividend Date | May 16, 2022 |
1y Target Est | 7.00 |
SALT LAKE CITY, Aug. 09, 2022 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) announced today that it will release financial results for its fourth quarter and full fiscal year ended June 30, 2022, after the stock market closes on Tuesday, August 23, 2022. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day. Investors interested in participating in the live call can dial (877) 704-4453 from the U.S. or international ca
It is hard to get excited after looking at LifeVantage's (NASDAQ:LFVN) recent performance, when its stock has declined...
Rare Key Ingredient Red Quinoa Activates Natural Collagen Synthesis and Increases Collagen Density by 42%SALT LAKE CITY, June 21, 2022 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a pioneer in nutrigenomics, hosted Activate 2022 throughout the Salt Lake City area last weekend. The event was one of the company’s largest in-person Distributor gathering since the beginning of the global pandemic, with over 6,000 U.S. distributors in attendance in person and remotely. The event featur